Delivery Order SPE2DE24DA017-SPE2D625F6W9R
- Not listed
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a delivery order valued at $1,871.46 on June 23, 2025, for the supply of ARTHREX ANGEL PRP Kit (US Tray). The contract is a fixed-price delivery order with economic price adjustment provisions and represents performance under Arthrex's larger Indefinite Delivery Contract (SPE2DE24D0020) with the Defense Logistics Agency's Medical Supply Chain. The delivery order carries an ultimate...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, received a fixed-price delivery order valued at $3,577.20 from the Defense Logistics Agency's Medical Supply Chain on August 1, 2025, with an ultimate completion date of August 6, 2025. The delivery order covers the Arthrex ANGEL PRP Kit for the U.S. market, a specialized medical device used in orthopedic procedures. This award was not set aside for any specific business category, reflecting...
- Arthrex Inc., a leading manufacturer of minimally invasive orthopedic medical technologies based in Naples, Florida, received a fixed-price delivery order from the Defense Logistics Agency's Medical Supply Chain on July 23, 2025, valued at $2,146.32. The order covers the supply of Arthrex ANGEL PRP Kits (autologous platelet-rich plasma kits) and is scheduled for completion by July 28, 2025. This delivery order was awarded without a set-aside designation, reflecting Arthrex's strong competitive...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, received a $12,520.20 fixed-price delivery order from the Defense Logistics Agency's Medical Supply Chain on August 7, 2025, for the ARTHREX ANGEL PRP Kit. The delivery order, which carries an ultimate completion date of August 12, 2025, was awarded without set-aside designation, reflecting Arthrex's competitive strength in the federal orthopedic medical device marketplace. This order represents a...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a delivery order valued at $1,430.88 on June 26, 2025, for the supply of ARTHREX ANGEL PRP Kits (US Tray). The contract is a fixed-price delivery order with economic price adjustment provisions and carries an ultimate completion date of July 1, 2025. This award was issued without a set-aside designation, reflecting Arthrex's competitive strength in the federal orthopedic medical device...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a delivery order valued at $18,183.64 by the Defense Logistics Agency's Medical Supply Chain on September 4, 2025. The delivery order, which carries a fixed-price contract type with economic price adjustment provisions, covers the supply of Arthrex ANGEL PRP Kits (US Tray) with a completion date of September 9, 2025. This award was not set aside for any specific business category,...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a delivery order valued at $5,365.80 for the ARTHREX ANGEL PRP KIT (US TRAY) on September 12, 2025. The contract is a fixed-price delivery order with economic price adjustment provisions and carries an ultimate completion date of September 17, 2025. This award was issued under a non-set-aside procurement by the Defense Logistics Agency's Medical Supply Chain, a defense-focused...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, received a $3,577.20 fixed-price delivery order from the Defense Logistics Agency's Medical Supply Chain on June 18, 2025, for orthopedic surgical kits, specifically a Centerline Sternal Displacement Arthroscopy Angel Life Platelet kit. This delivery order, with an ultimate completion date of June 27, 2025, carries no set-aside designation, reflecting Arthrex's strong competitive position in the...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, received a delivery order valued at $23,663.30 from the Defense Logistics Agency's Medical Supply Chain on June 2, 2025. The delivery order, classified as fixed-price with economic price adjustment pricing, is for an ANGEL Centrifuge Angel Concentrate Platelet Rich Plasma System kit. This award represents a task order under Arthrex's larger Indefinite Delivery Contract (SPE2DE24D0020) with the...
- Arthrex Inc., a global leader in minimally invasive orthopedic medical technologies headquartered in Naples, Florida, received a $15,862.76 fixed-price delivery order from the Defense Logistics Agency's Medical Supply Chain on September 2, 2025, for an ACD-A 13G Open Tip BMA Angel Kit. This delivery order represents a task order issued under Arthrex's larger Indefinite Delivery Contract (SPE2DE24D0020) with the Defense Logistics Agency, valued at $471,048,172.66 and running through September...
- SPE2DE24DA017Indefinite Delivery Contract
- SPE2DE24DA017-SPE2D625F6W9RDelivery Order
Arthrex Inc., a leading developer and manufacturer of minimally invasive orthopedic medical technologies headquartered in Naples, Florida, received a fixed-price delivery order valued at $3,577.20 from the Defense Logistics Agency's Medical Supply Chain on May 8, 2025. The order, which has an ultimate completion date of May 13, 2025, calls for delivery of an ARTHREX ANGEL PRP Kit (US Tray)—a specialized orthopedic medical device used in platelet-rich plasma procedures. The contract was awarded on a competitive basis without set-aside provisions, reflecting Arthrex's strong competitive standing in the federal orthopedic medical device marketplace. The pricing structure includes economic price adjustment provisions to account for potential cost fluctuations during the delivery period. This delivery order was issued under Arthrex's comprehensive Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (SPE2DE24D0020), valued at $471 billion and spanning from June 11, 2024, through September 1, 2029. The parent IDC enables Veterans Affairs medical centers and military healthcare systems nationwide to efficiently procure Arthrex's full portfolio of orthopedic solutions, including surgical implants, arthroscopic instruments, and specialized surgical kits. To date, Arthrex has generated over $550,000 in delivery orders under this vehicle, demonstrating consistent demand for its innovative orthopedic technologies across the federal healthcare system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.6k | 5/8/25 |